Encapsulated Cell Therapy
Showing 1 - 25 of >10,000
Retinitis Pigmentosa, Usher Syndrome Type 2, Usher Syndrome Type 3 Trial in San Francisco (NT-501, Sham)
Completed
- Retinitis Pigmentosa
- +2 more
- NT-501
- Sham
-
San Francisco, CaliforniaUniversity of California, San Francisco
Apr 14, 2022
Acute-On-Chronic Liver Failure, Chronic Liver Failure Trial (a single course of micro-encapsulated hepatocytes intraperitoneal
Not yet recruiting
- Acute-On-Chronic Liver Failure
- Chronic Liver Failure
- a single course of micro-encapsulated hepatocytes intraperitoneal transplantation therapy
- (no location specified)
Feb 13, 2023
Glaucoma Trial in Palo Alto (NT-501, Sham comparator)
Recruiting
- Glaucoma
- NT-501
- Sham comparator
-
Palo Alto, CaliforniaByers Eye Institute at Stanford University
Aug 13, 2021
Glaucoma Trial in Palo Alto (NT-501 ECT implant, Sham)
Active, not recruiting
- Glaucoma
- NT-501 ECT implant
- Sham
-
Palo Alto, CaliforniaByers Eye Institute at Stanford University
Aug 13, 2021
Hemophilia A Trial in United Kingdom, United States (SIG-001)
Terminated
- Hemophilia A
- SIG-001
-
Indianapolis, Indiana
- +5 more
Nov 7, 2022
Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Acute Myeloid Leukemia Arising
Not yet recruiting
- Acute Myeloid Leukemia
- +4 more
- Azacitidine
- +6 more
- (no location specified)
Nov 8, 2022
Recurrent Classic Hodgkin Lymphoma, Refractory Classic Hodgkin Lymphoma Trial (procedure, drug, biological, radiation, other)
Not yet recruiting
- Recurrent Classic Hodgkin Lymphoma
- Refractory Classic Hodgkin Lymphoma
- Autologous Hematopoietic Stem Cell Transplantation
- +13 more
- (no location specified)
Feb 2, 2023
Type 1 Diabetes Trial in Amsterdam (encapsulated autologous fecal microbiota transplantation)
Recruiting
- Type 1 Diabetes
- encapsulated autologous fecal microbiota transplantation
-
Amsterdam, Please Select, NetherlandsAcademisch Medisch Centrum
Apr 5, 2022
Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Tumor, Acute Myeloid
Not yet recruiting
- Acute Myeloid Leukemia
- +3 more
- Azacitidine
- +6 more
- (no location specified)
Nov 15, 2022
Oral Cancer Trial in Cairo (Quercetin 3,3',4',5,6-Pentahydroxyflavone,
Not yet recruiting
- Oral Cancer
- Quercetin 3,3',4',5,6-Pentahydroxyflavone, 2-(3,4-Dihydroxyphenyl)-3,5,7-trihydroxy-4H-1-benzopyran-4-one
- +2 more
-
Cairo, Egypt11 Saraya El Manial
Jul 8, 2022
Allergy, Peanut, Peanut Allergy, Peanut Hypersensitivity Trial in Boston (biological, drug, other)
Not yet recruiting
- Allergy, Peanut
- +5 more
- Microbial Transplantation Therapy
- +3 more
-
Boston, MassachusettsBoston Children's Hospital
Jan 23, 2023
MPS I, MPS1-S, MPS1-HS Trial in Porto Alegre, London, Salford (SIG-005 (hIDUA Producing Spheres))
Withdrawn
- MPS I
- +2 more
- SIG-005 (hIDUA Producing Spheres)
-
Porto Alegre, Brazil
- +2 more
Dec 16, 2022
NSCLC Stage IV, Melanoma Stage IV, Unresectable Melanoma Trial in Montréal (Camu Camu Capsules (Camu Camu powder encapsulated
Recruiting
- NSCLC Stage IV
- +3 more
- Camu Camu Capsules (Camu Camu powder encapsulated (500mg each) + ICI
-
Montréal, Quebec, CanadaCentre hospitalier de l'Université de Montréal (CHUM)
Jul 18, 2022
Acute Myeloid Leukemia, Acute Myeloid Leukemia With Multilineage Dysplasia, Chronic Myelomonocytic Leukemia Trial in Chapel
Recruiting
- Acute Myeloid Leukemia
- +5 more
- Biospecimen Collection
- +3 more
-
Baltimore, Maryland
- +2 more
Jan 19, 2023
Recurrent Acute Myeloid Leukemia, Recurrent B Acute Lymphoblastic Leukemia, Recurrent Mixed Phenotype Acute Leukemia Trial
Not yet recruiting
- Recurrent Acute Myeloid Leukemia
- +7 more
- Anti-CD123 ADC IMGN632
- +7 more
- (no location specified)
Dec 28, 2022
Heart Failure, Mechanical Circulatory Support Trial in Ljubljana (CD34+ stem cell therapy)
Recruiting
- Heart Failure
- Mechanical Circulatory Support
- CD34+ stem cell therapy
-
Ljubljana, SloveniaUniversity Medical Center Ljubljana
Nov 22, 2023
ASCT Versus Chemotherapy as First-Line Consolidation Therapy
Completed
- T-cell Lymphoma Adults
- consolidation with ASCT
- (no location specified)
Nov 25, 2023
B-cell Acute Lymphoblastic Leukemia, B-cell Lymphoma, Diffuse Large B Cell Lymphoma Trial in Beijing (CD19/CD22-bispecific CAR-T
Recruiting
- B-cell Acute Lymphoblastic Leukemia
- +2 more
- CD19/CD22-bispecific CAR-T cells
-
Beijing, Beijing, ChinaLiang Wang
Oct 7, 2023
Lymphoma, B-Cell, Relapsed Cancer, Refractory Lymphoma Trial in Boston (Adaptive Bridging Radiation Therapy (ABRT))
Not yet recruiting
- Lymphoma, B-Cell
- +7 more
- Adaptive Bridging Radiation Therapy (ABRT)
-
Boston, MassachusettsDana-Farber Cancer Institute
Aug 16, 2023
Resectable Lung Non-Small Cell Carcinoma Trial in Atlanta (procedure, radiation, other)
Not yet recruiting
- Resectable Lung Non-Small Cell Carcinoma
- Biospecimen Collection
- +2 more
-
Atlanta, GeorgiaEmory University Hospital/Winship Cancer Institute
Aug 22, 2023
T Lymphoblastic Leukemia/Lymphoma Trial in Hangzhou (Chidamide)
Recruiting
- T Lymphoblastic Leukemia/Lymphoma
-
Hangzhou, Zhejiang, ChinaThe First Hospital of Zhejiang Medical Colleage Zhejiang Univers
Aug 7, 2023
Primary Mediastinal Large B-cell Lymphoma (PMBCL), Primary Mediastinal Large B Cell Lymphoma, Primary Mediastinal Large B-Cell
Not yet recruiting
- Primary Mediastinal Large B-cell Lymphoma (PMBCL)
- +5 more
- Pembrolizumab
- +3 more
-
Boston, Massachusetts
- +1 more
Jun 28, 2023
Neoadjuvant Therapy for Esophageal Squamous Cell Carcinoma
Recruiting
- Esophageal Squamous Cell Carcinoma
-
Shijiazhuang, Hebei, ChinaDepartment of Thoracic Surgery, Fourth Hospital of Hebei Medical
Oct 25, 2023
Recurrent DLBCL, Refractory DLBCL Trial in Duarte (procedure, biological, radiation)
Not yet recruiting
- Recurrent Diffuse Large B-Cell Lymphoma
- Refractory Diffuse Large B-Cell Lymphoma
- Biospecimen Collection
- +6 more
-
Duarte, CaliforniaCity of Hope Medical Center
Mar 24, 2023
Large B-cell Lymphoma, Relapsed Non-Hodgkin Lymphoma Trial in Tampa (Comprehensive Ablative Bridging Irradiation (CABI),
Recruiting
- Large B-cell Lymphoma
- Relapsed Non-Hodgkin Lymphoma
- Comprehensive Ablative Bridging Irradiation (CABI)
- Chimeric Antigen Receptor T-Cell Therapy
-
Tampa, FloridaMoffitt Cancer Center
Oct 26, 2023